The Institute for Safe Medication Practices (ISMP) and Vermont Oxford Network have collaborated on a table of standard concentrations of neonatal drug infusions.
The table was developed with the assistance of representatives from U.S. neonatal intensive care units.
According to a description of the table, which is published on the ISMP website, the safety benefits of all hospitals using the same standard concentrations for neonates include the following:
- Reduce medication error risk when critically-ill neonates are transferred from one facility to another
- Stimulate development of standardized infusion device drug libraries
- Provide the demand necessary for manufacturers to offer commercially prepared standard solutions (if not already available), thereby reducing the risk of extemporaneous compounding errors within hospitals.
Download the table on standard concentrations of neonatal drug infusions (pdf).
Download other patient safety-related tools and resources: